C. BERTONI ET AL.: "Enhanced gene repair mediated by methyl-CpG-modified single-stranded oligonucleotides", NUCLEIC ACIDS RESEARCH, vol. 37, no. 22, 1 December 2009 (2009-12-01), pages 7468-7482, XP055083881, ISSN: 0305-1048, DOI: 10.1093/nar/gkp757 (B1)

G. DE PIÉDOUE ET AL: "Targeted gene correction with 5' Acridine-oligonucleotide conjugates", OLIGONUCLEOTIDES, vol. 17, no. 2, 1 June 2007 (2007-06-01), pages 258-263, XP055083891, ISSN: 1545-4576, DOI: 10.1089/oli.2007.0074 (B1)

IGOUCHEVA O. ET AL.: "Targeted gene correction by small single-stranded oligonucleotides in mammalian cells", GENE THERAPY, NATURE PUBLISHING GROUP, GB, vol. 8, no. 5, 1 March 2001 (2001-03-01), pages 391-399, XP001206900, ISSN: 0969-7128, DOI: 10.1038/SJ.GT.3301414 (B1)

IOANNIS PAPAIOANNOU ET AL.: "Use of internally nuclease-protected single-strand DNA oligonucleotides and silencing of the mismatch repair protein, MSH2, enhances the replication of corrected cells following gene editing", THE JOURNAL OF GENE MEDICINE, vol. 11, no. 3, 1 March 2009 (2009-03-01), pages 267-274, XP055083882, ISSN: 1099-498X, DOI: 10.1002/jgm.1296 (B1)

JULIA U. ENGSTROM ET AL.: "Regulation of targeted gene repair by intrinsic cellular processes", BIOESSAYS, vol. 31, no. 2, 1 February 2009 (2009-02-01), pages 159-168, XP055083884, ISSN: 0265-9247, DOI: 10.1002/bies.200800119 (B1)

K.K. GONCZ ET AL.: "Expression of [Delta]F508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR", GENE THERAPY, vol. 8, no. 12, 1 June 2001 (2001-06-01), pages 961-965, XP55087004, ISSN: 0969-7128, DOI: 10.1038/sj.gt.3301476 (B1)

YING SHEN ET AL: "RNA-driven genetic changes in bacteria and in human cells", MUTATION RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 717, no. 1, 31 March 2011 (2011-03-31), pages 91-98, XP028101777, ISSN: 0027-5107, DOI: 10.1016/J.MRFMMM.2011.03.016 [retrieved on 2011-04-14] (B1)

MCLACHLAN J. ET AL.: "Specific targeted gene repair using single-stranded DNA oligonucleotides at an endogenous locus in mammalian cells uses homologous recombination", DNA REPAIR, ELSEVIER, AMSTERDAM, NL, vol. 8, no. 12, 3 December 2009 (2009-12-03), pages 1424-1433, XP026783991, ISSN: 1568-7864, DOI: 10.1016/J.DNAREP.2009.09.014 [retrieved on 2009-10-24] (B1)

OLGA IGOUCHEVA ET AL.: "Oligonucleotide-mediated gene targeting in human hepatocytes: implications of mismatch repair", OLIGONUCLEOTIDES, vol. 18, no. 2, 1 June 2008 (2008-06-01), pages 111-122, XP055083886, ISSN: 1545-4576, DOI: 10.1089/oli.2008.0120 (B1)

PAPAIOANNOU IOANNIS ET AL.: "Oligonucleotide-directed gene-editing technology: mechanisms and future prospects", EXPERT OPINION ON BIOLOGICAL THERAPY, INFORMA HEALTHCARE, UK, vol. 12, no. 3, 1 March 2012 (2012-03-01), pages 329-342, XP009161686, ISSN: 1744-7682 (B1)

PETRA DISTERER ET AL.: "Oligonucleotide-mediated gene editing is underestimated in cells expressing mutated green fluorescent protein and is positively associated with target protein expression", THE JOURNAL OF GENE MEDICINE, vol. 14, no. 2, 20 February 2012 (2012-02-20), pages 109-119, XP055083874, ISSN: 1099-498X, DOI: 10.1002/jgm.1639 (B1)

THORPE P. ET AL.: "Optimising gene repair strategies in cell culture", GENE THERAPY, NATURE PUBLISHING GROUP, GB, vol. 9, no. 11, 1 June 2002 (2002-06-01), pages 700-702, XP009004392, ISSN: 0969-7128, DOI: 10.1038/SJ.GT.3301750 (B1)

WO-A2-2005/094370 (B1)

LIVINGSTON PAULA ET AL.: "Oligonucleotide delivery by nucleofection does not rescue the reduced proliferation phenotype of gene-edited cells.", NUCLEIC ACID THERAPEUTICS, vol. 22, no. 6, December 2012 (2012-12), pages 405-413, XP002716113, ISSN: 2159-3345 (B1)